Clinical trials: Locally Advanced or Metastatic Solid Tumors for Phase 1, Dose Escalation and Phase 2 Safety Lead-in
- Condition Locally Advanced or Metastatic Solid Tumors for Phase 1, Dose Escalation and Phase 2 Safety Lead-in
- Funder type Industry (pharma, biotech, devices)
We couldn't retrieve this information right now
The trial registry didn't respond. This is usually temporary — please try again in a moment.